Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors

PaperCitations, authors & open-access status

The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 158 citations, 2013 year and hybrid oa status.

158
Citations
2013
Year
hybrid
OA Status

Related on ScholarIQ

Sergio Gloger
Author
CNS Drugs
Journal
Dementia and Cognitive Impairment Research
Topic
Dementia and Cognitive Impairment Research
Topic
Cholinesterase and Neurodegenerative Diseases
Topic
Alzheimer's disease research and treatments
Topic
470M+ articles · free account